Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Many peptides discussed in this article are not FDA-approved for the uses described and are used off-label in clinical settings
Cord-blood infusion has been tested in adult ischemic stroke, supporting safety and feasibility while leaving questions about efficacy and optimal patient selection [39]
Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT)
US$ 22.69
US$ 22.27
US$ 25.79
US$ 21.60
US$ 28.47
US$ 22.89
US$ 25.52
US$ 24.07
US$ 21.81
US$ 20.70
US$ 28.09
US$ 27.96
